Source: FinanzNachrichten

Sonoma Pharmaceuticals: Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

BOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypoc...

Read full article »
Annual Revenue
$5.0-25M
Employees
100-250
CEO Avatar

Interim-CEO

Amy Trombly

CEO Approval Rating

89/100

Read more